DNM1L and ovarian carcinoma: Based on this and our current finding (Figure 1) we hypothesized that elevated Drp1 levels in epithelial ovarian cancer (EOC) would be necessary for promoting cell proliferation in the EOC patients, where a specific cell cycle pathway was found to be perturbed in greater than 80% of the patients [34].